Biosenta Inc. develops and sells chemical compounds for household and industrial applications in Canada, including an anti-microbial disinfectant. While the company boasts a gross margin of 50.8%, it faces significant concerns with a severely negative EBITDA margin and net margin, indicating operational inefficiencies. Additionally, its current and quick ratios suggest poor liquidity, raising red flags about its ability to meet short-term obligations. The recent 100% price increase may reflect speculative interest rather than underlying financial stability, warranting cautious consideration for potential investors.
Loading financial metrics...
Company has $5K in cash but burned $104K last quarter. At this burn rate, only 0.0 quarters of runway remain without additional financing.
Company posted a loss of $-2.6M over the last year, representing -1302.8% of revenue.
Debt of $6.4M is 1357.3x the company's cash position of $5K.
Operating cash flow has been negative for 3 consecutive quarters, burning $416K over the last year.
Low debt-to-revenue ratio of -3212.6% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Household & Personal Products companies of a similar size
Based on 2025-Q2 (June 30, 2025)